Oliver P. Peoples, Ph.D. is the President and Chief Executive Officer of Yield10 Bioscience. Previously, Dr. Peoples was a co-founder of Metabolix and served as its Chief Scientific Officer and Vice President of Research and Development from January 2000 until October 2016, and also served as director of the Company since June 1992.
Prior to founding Metabolix, Dr. Peoples was a research scientist with the Department of Biology at the Massachusetts Institute of Technology where he emerged as a pioneer of the new field of metabolic pathway engineering and its applications in industrial biotechnology. The research carried out by Dr. Peoples at MIT established the fundamental tools and methods for engineering bacteria and plants to produce Mirel biopolymers. Dr. Peoples has published numerous peer reviewed academic papers and is an inventor of over 90 patents and patent applications worldwide. Dr. Peoples received a Ph.D. in Molecular Biology from the University of Aberdeen, Scotland.
While we look forward to additional patents being granted on our inventions in 2019 and beyond, we continue to protect our discoveries with new filings. In 2019 alone, we have filed new patent applications related to our GRAIN technology platform as well as the use of our Camelina platform to cost-effectively produce PHA/PHB biomaterials. The growth of our intellectual property portfolio is a direct reflection of the innovative capabilities of our team.